查尔斯河实验室 CRL 深 沪
等待开盘 10-19 09:30:00 美东时间
300.15
-6.090
-1.99%
华盛通- 最 高308.83
- 今 开306.09
- 成交量 67.46万股
- 最 低 296.3537
- 昨 收 306.24
- 总市值 143.29亿
- 52周最高 333.295
- 市盈率 静 --
- 换手率 1.41%
- 52周最低 146.195
- 委 比 -66.67%
- 总股本 4773.89万
- 历史最高 460.21
- 量 比 0.88
- 振 幅 4.07%
- 历史最低 25.52
- 每 手 1
- 风险率 45.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多查尔斯河实验室收跌1.99%，成交额2.03亿美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 04:49
AI制药最大的受益者出现了
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-16 07:40
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340
Morgan Stanley analyst Ricky Goldwasser maintains Charles River (NYSE:CRL) with a Overweight and raises the price target from $300 to $340.
10-14 00:24
Charles River Laboratories and Autolomous Launch Apollo Orchestrate To Digitize Laboratory Execution Through autoloMATE Integration
Partnership reinforces continued investment in digitization, automation, and client-facing transparency Charles River Laboratories International, Inc. (NYSE:CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new capability within Charles River's Apollo® platform that connects a...
10-06 20:13
美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling over 150 points on Thursday. Shares of Everpure, Inc. (NYSE:P) rose sharply after the data storage company outlined a broader growth strategy and issued a preliminary fiscal 2028 outlook at its 2026 Financial Analyst Meeting. The company also...
09-24 22:01
美股大行评级 | Adobe绩后获多家大行齐升目标价！最高看多至270美元；甲骨文绩后现多空分歧
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从10美元升至10.5美元；摩根士丹利：维持Aurora Innovation"超配"评级，目标价从14美元升至18美元
09-14 16:05
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $320
Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and raises the price target from $300 to $320.
09-11 23:31
